http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3092379-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c9284d9231b15440b3ba4c8904ab71a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2200-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N20-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T13-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-11
filingDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20b5985bee2c3c8fcd813259af411c13
publicationDate 2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3092379-A1
titleOfInvention 3-dimensional representations of post-contrast enhanced brain lesions
abstract Methods, apparatuses, systems, and implementations for creating 3 -dimensional (3D) representations exhibiting geometric and surface characteristics of post-contrast brain lesions are disclosed. 3D MRI images of the brain may be created and acquired. After administration of a contrast substance, brain lesions and other abnormalities may be identified and isolated from the 3D MRI images, with each lesion serving as a region of interest (ROI). 3D region of contrast enhancement images may be created from segmented 3D MRI images and different regions of contrast enhancement of the brain lesion may be depicted. Saved regions of contrast enhancement may be converted into stereolithography format, maximum intensity projection (MIP) images, and/or orthographic projection images. Data corresponding to these resulting 3D region of contrast enhancement images may be used to create 3D printed models of the isolated region of contrast enhancement using 3D printing technology. Analysis of the 3D brain region of contrast enhancement images and the 3D printed region of contrast enhancement models may enable a more efficient and accurate way of determining brain lesion risk factors and effective treatment regimens.
priorityDate 2018-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70678987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556073

Total number of triples: 34.